FO
Forian Inc.
FORA · NASDAQ
$2.17 +0.00% (+$0.00)
Market Cap $67.8M
P/E Ratio -
Div. Yield -
ROE 9.43%
Bulios Fair Price
$1.98
8.8% downside
Current Price
$2.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, FORA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
66 /100
Fair P/S 2.24x
P/B 2.28x
P/FCF 23.49x
Growth
100 /100
Growing Rev. growth 234.98%
Book val. growth 35.00%
EPS growth N/A
Profitability
39 /100
Moderate Gross margin 53.21%
Net margin 9.50%
Op. margin 12.44%
Quality
9 /100
Poor ROIC 11.55%
ROE 9.43%
ROA 6.51%
Debt
49 /100
Moderate Debt/Equity 0.00x
Current ratio 2.97x
Int. coverage -3.25x
Stability
25 /100
Unstable Beta 0.93x
Rev. volatility 1,724.55%
EPS volatility 279.30%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FORA
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Max C. Wygod
Employees
47
Headquarters
Newtown